Clinicodemographic factors influencing outcomes in patients with low-grade serous ovarian carcinoma
Is low-grade serous ovarian cancer part of the tumor spectrum of hereditary breast and ovarian cancer?
Low-grade serous primary peritoneal carcinoma
Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo
Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis
The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer
The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma
Previous
Previous
2012
Next
Next